HOME >> BIOLOGY >> NEWS
Bacteriophage genomics approach to antimicrobial drug discovery published in Nature Biotechnology

MONTREAL, CANADA (January 12, 2004): Identifying the targets that bacterial viruses, or phages, use to halt bacterial growth and then screening against those targets for small molecule inhibitors that attack the same targets provides a unique platform for the discovery of novel antibiotics. Researchers from Montreal-based PhageTech, Inc. describe in the February issue of Nature Biotechnology this novel method for discovering new classes of antibiotics. The article is available on-line today at www.nature.com/nbt/.

"Over the course of evolution, the multitudes of phages that attack bacteria have developed unique proteins that bind to and inactivate (or redirect) critical cellular targets within their prey," said Jing Liu, Ph.D., corresponding author of the publication. "This binding shuts off key metabolic processes in the bacteria, diverting those organisms from their own growth and reproduction to the production of new phage progeny. We believe these phage-identified bacterial "weak spots" will provide useful screening targets for discovering the sorts of truly novel antibiotics needed to combat growing antibiotic resistance."

The publication's authors used a high-throughput phage genomics strategy to identify novel 31 novel polypeptide families that inhibit Staphylococcus aureus growth when expressed in the bacteria. Several of these were found to attack targets essential for bacterial DNA replication or transcription. They then employed the interaction between a prototypic phage peptide, ORF104 of phage 77, and its bacterial target, DnaI, to screen for small molecule inhibitors. Using this strategy, the researchers found several novel compounds that inhibited both bacterial growth and DNA synthesis.

"This strategy offers several benefits as a novel approach to antimicrobial drug discovery," said Jinzi J. Wu, M.D., Ph.D., PhageTech vice president, R&D - biology. "First, the bacterial targets identifi
'"/>

Contact: Joan Kureczka
JKureczka@aol.com
415-821-2413
Kureczka/Martin Associates
11-Jan-2004


Page: 1 2

Related biology news :

1. International symposium on nutritional genomics
2. APS announces the winners of its 2004 postdoctoral fellowship in physiological genomics
3. Full promise of genomics in disease research yet to be realized
4. Pharmacogenomics could replace trial-and-error with science from the human genome
5. Dartmouth Medical School awarded $9 million grant for genomics research
6. Functional genomics enables easy target identification and drives drug discovery
7. Library on a Slide: Whole genome microarrays for comparative genomics
8. New genomics tool boosts diabetes research
9. Emerging frontiers genomics grant for blue-green bacteria
10. What can the genomics revolution teach us about global change?
11. Hot topics in pharmacogenomics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... POWAY, Calif. (PRWEB) , ... October 16, 2018 , ... ... taken to look for a possible tumor and instead, Sam’s veterinarian found that he ... not experiencing any obvious discomfort, so his owner placed him on supplements for the ...
(Date:10/16/2018)... ... October 15, 2018 , ... Modality Solutions, ... regulated industries, is a silver sponsor and exhibitor at the Executive Platforms’ Biomanufacturing ... The Biomanufacturing World Summit brings together the “who’s who” of pharmaceutical executives, cutting-edge ...
(Date:10/16/2018)... Utah and BOSTON (PRWEB) , ... ... ... CallTower , a global leader in delivering cloud-based enterprise-class unified communications and ... Boost delivers enhanced network stability by directly connecting CallTower data centers to ...
Breaking Biology News(10 mins):
(Date:10/3/2018)... (PRWEB) , ... October 03, 2018 , ... Milwaukee Area ... open house Wednesday, Oct. 17, from 3-7 p.m. in Room T129 in the T ... to its new CNC Swiss Lab. A ribbon cutting and formal program will be ...
(Date:10/2/2018)... ... 2018 , ... The Alliance for Clinical Research Excellence and ... standards and testing of procedures for voluntary accreditation of clinical research sites. The ... Quality Management Systems and Chief Quality Officer, is underway in association with ...
(Date:9/27/2018)... ... September 26, 2018 , ... ... Melina Cimler, a senior quality, regulatory, and in vitro diagnostic device expert with ... diagnostic industry has joined the firm as an Expert Consultant. Her experience includes ...
(Date:9/27/2018)... ... September 27, 2018 , ... ... Everwell Health Solutions and SureAdhere Mobile Technology, Inc. announced they will formally merge ... in the battle against tuberculosis (TB) and other diseases. These two social enterprise ...
Breaking Biology Technology:
Cached News: